Americares, in partnership with the Healthcare Distribution Alliance, presented its annual Power of Partnership Award to Teva ...

Patent lawyers are racing to adapt how they draft and defend drug-device patents after a court ruling reshaped the FDA’s ...

NORTHAMPTON, MA / ACCESS Newswire / June 10, 2025 / Teva Pharmaceuticals has been recognized with the 2025 Power of ...

Chicago, IL – June 10, 2025 – Today, Zacks Equity Research discusses Sandoz SDZNY, Teva Pharmaceuticals TEVA and Viatris VTRS ...

Goldman Sachs initiates Teva, Viatris, and Amneal, highlighting branded growth and pipeline strength, but one company's ...

From five years of sales declines to nine consecutive quarters of growth, it’s hard to deny that Teva’s revamp under CEO Richard Francis is paying off. | By 2030, Teva now expects to achieve at least ...

Francis added that when he came to Teva he sensed the market’s skepticism about the company’s ability to return to innovative ...

Teva Pharmaceuticals’ share prices declined by 13.89 percent on Wednesday to finish at $18.54 each after announcing ...

In this article, we are going to take a look at where Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) stands against other biggest gainers of last week. Investors gobbled up shares of ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced results from a study of treatment patterns among patients with tardive dyskinesia (TD) residing in ...

Teva Pharmaceuticals announced that Fitch Ratings has upgraded its corporate credit rating from BB to BB+, maintaining a stable outlook. This upgrade reflects Teva's efforts to reduce debt ...

Teva Pharmaceuticals TEVA0.12%increase; green up pointing triangle will pay $450 million to resolve allegations that the generic drug manufacturer submitted false claims and violated a federal law ...